HDX
gene geneOn this page
Also known as FLJ30678
Summary
HDX (highly divergent homeobox, HGNC:26411) is a protein-coding gene on chromosome Xq21.1, encoding Highly divergent homeobox (Q7Z353).
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be located in chromatin.
Source: NCBI Gene 139324 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 142 total
- MANE Select transcript:
NM_001177479
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26411 |
| Approved symbol | HDX |
| Name | highly divergent homeobox |
| Location | Xq21.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ30678 |
| Ensembl gene | ENSG00000165259 |
| Ensembl biotype | protein_coding |
| OMIM | 300994 |
| Entrez | 139324 |
Gene structure
Transcript identifiers
Ensembl transcripts: 15 — 13 protein_coding, 1 protein_coding_CDS_not_defined, 1 retained_intron
ENST00000297977, ENST00000373177, ENST00000449553, ENST00000465509, ENST00000472135, ENST00000506585, ENST00000851223, ENST00000851224, ENST00000851225, ENST00000851226, ENST00000851227, ENST00000933426, ENST00000933427, ENST00000933428, ENST00000951003
RefSeq mRNA: 3 — MANE Select: NM_001177479
NM_001177478, NM_001177479, NM_144657
CCDS: CCDS35342, CCDS55456
Canonical transcript exons
ENST00000373177 — 11 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001091691 | 84333759 | 84333842 |
| ENSE00001091692 | 84336801 | 84336880 |
| ENSE00001091693 | 84326178 | 84326300 |
| ENSE00001091696 | 84440532 | 84440585 |
| ENSE00001091697 | 84361466 | 84361612 |
| ENSE00001091699 | 84344250 | 84344457 |
| ENSE00001331631 | 84475251 | 84475397 |
| ENSE00001459720 | 84488024 | 84488132 |
| ENSE00002027855 | 84317878 | 84322014 |
| ENSE00003696830 | 84468472 | 84469575 |
| ENSE00003737820 | 84502342 | 84502453 |
Expression profiles
Bgee: expression breadth ubiquitous, 162 present calls, max score 85.59.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 5.1858 / max 166.3849, expressed in 1404 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 199861 | 4.5471 | 1356 |
| 199862 | 0.6387 | 353 |
Top tissues by expression
245 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 85.59 | gold quality |
| calcaneal tendon | UBERON:0003701 | 80.03 | gold quality |
| ganglionic eminence | UBERON:0004023 | 79.32 | gold quality |
| cortical plate | UBERON:0005343 | 77.12 | gold quality |
| popliteal artery | UBERON:0002250 | 75.54 | gold quality |
| tibial artery | UBERON:0007610 | 75.49 | gold quality |
| monocyte | CL:0000576 | 75.28 | gold quality |
| leukocyte | CL:0000738 | 74.72 | gold quality |
| ventricular zone | UBERON:0003053 | 74.54 | gold quality |
| aorta | UBERON:0000947 | 73.82 | gold quality |
| islet of Langerhans | UBERON:0000006 | 73.77 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 73.44 | gold quality |
| adrenal tissue | UBERON:0018303 | 73.21 | gold quality |
| stromal cell of endometrium | CL:0002255 | 72.48 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 72.09 | gold quality |
| ascending aorta | UBERON:0001496 | 71.98 | gold quality |
| thoracic aorta | UBERON:0001515 | 71.98 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 71.08 | gold quality |
| left coronary artery | UBERON:0001626 | 70.90 | gold quality |
| gall bladder | UBERON:0002110 | 69.96 | gold quality |
| coronary artery | UBERON:0001621 | 68.96 | gold quality |
| right ovary | UBERON:0002118 | 68.65 | gold quality |
| ectocervix | UBERON:0012249 | 68.45 | gold quality |
| left ovary | UBERON:0002119 | 68.33 | gold quality |
| body of uterus | UBERON:0009853 | 68.14 | gold quality |
| right coronary artery | UBERON:0001625 | 67.40 | gold quality |
| endocervix | UBERON:0000458 | 67.33 | gold quality |
| mucosa of stomach | UBERON:0001199 | 67.01 | gold quality |
| tibial nerve | UBERON:0001323 | 66.71 | gold quality |
| prefrontal cortex | UBERON:0000451 | 66.57 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-100618 | yes | 188.14 |
| E-CURD-10 | no | 270.25 |
| E-ANND-3 | no | 4.73 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
196 targeting HDX, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-4768-5P | 100.00 | 69.49 | 2861 |
| HSA-MIR-6833-3P | 100.00 | 70.63 | 3197 |
| HSA-MIR-3646 | 100.00 | 73.56 | 5283 |
| HSA-MIR-340-5P | 100.00 | 72.50 | 4437 |
| HSA-MIR-1277-5P | 100.00 | 73.95 | 5056 |
| HSA-MIR-6867-5P | 100.00 | 82.21 | 3464 |
| HSA-MIR-7110-3P | 100.00 | 73.18 | 2486 |
| HSA-MIR-4668-3P | 100.00 | 68.74 | 2635 |
| HSA-MIR-513A-5P | 100.00 | 69.77 | 2465 |
| HSA-MIR-3185 | 99.99 | 68.12 | 1959 |
| HSA-MIR-548AW | 99.99 | 72.57 | 3559 |
| HSA-MIR-513B-5P | 99.99 | 69.96 | 2150 |
| HSA-MIR-3662 | 99.99 | 73.82 | 5684 |
| HSA-MIR-4500 | 99.99 | 72.72 | 2367 |
| HSA-MIR-186-5P | 99.99 | 70.83 | 3707 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-4531 | 99.99 | 69.70 | 3181 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-LET-7B-5P | 99.98 | 72.31 | 1790 |
| HSA-LET-7G-5P | 99.98 | 72.37 | 1784 |
| HSA-LET-7I-5P | 99.98 | 72.37 | 1788 |
| HSA-MIR-4482-3P | 99.98 | 72.50 | 3147 |
| HSA-MIR-548N | 99.98 | 71.94 | 4170 |
| HSA-LET-7A-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7C-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7E-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7F-5P | 99.98 | 72.56 | 1784 |
Literature-anchored findings (GeneRIF, showing 1)
- HDX negatively regulates EPAS1 expression through a release-of-inhibition mechanism. (PMID:29577908)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | hdx | ENSDARG00000079382 |
| mus_musculus | Hdx | ENSMUSG00000034551 |
| rattus_norvegicus | Hdx | ENSRNOG00000037799 |
| drosophila_melanogaster | acj6 | FBGN0000028 |
| caenorhabditis_elegans | WBGENE00006818 |
Paralogs (17): POU2F2 (ENSG00000028277), POU1F1 (ENSG00000064835), POU4F3 (ENSG00000091010), POU6F2 (ENSG00000106536), POU2F3 (ENSG00000137709), POU2F1 (ENSG00000143190), POU4F2 (ENSG00000151615), POU4F1 (ENSG00000152192), POU6F1 (ENSG00000184271), POU3F2 (ENSG00000184486), POU3F1 (ENSG00000185668), POU3F4 (ENSG00000196767), POU3F3 (ENSG00000198914), CCDC160 (ENSG00000203952), POU5F1 (ENSG00000204531), POU5F1B (ENSG00000212993), POU5F2 (ENSG00000248483)
Protein
Protein identifiers
Highly divergent homeobox — Q7Z353 (reviewed: Q7Z353)
All UniProt accessions (2): E2QRN0, Q7Z353
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Nucleus.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q7Z353-1 | 1 | yes |
| Q7Z353-2 | 2 |
RefSeq proteins (3): NP_001170949, NP_001170950, NP_653258 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001356 | HD | Domain |
| IPR009057 | Homeodomain-like_sf | Homologous_superfamily |
| IPR050255 | POU_domain_TF | Family |
UniProt features (27 total): cross-link 10, region of interest 4, helix 3, compositionally biased region 3, DNA-binding region 2, sequence variant 2, chain 1, splice variant 1, turn 1
Structure
Experimental structures (PDB)
1 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 2DA4 | SOLUTION NMR |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q7Z353-F1 | 56.42 | 0.23 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (10): 135, 140, 144, 163, 172, 194, 212, 221, 232, 613
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 108 (showing top):
TGCGCANK_UNKNOWN, CREBP1_Q2, CREB_Q4, WTGAAAT_UNKNOWN, E4F1_Q6, AACTTT_UNKNOWN, TGGNNNNNNKCCAR_UNKNOWN, CREBP1CJUN_01, CREB_01, TGACGTCA_ATF3_Q6, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, CREB_Q2, chrXq21, SREBP_Q3, GSE13522_WT_VS_IFNG_KO_SKING_T_CRUZI_Y_STRAIN_INF_DN
GO Biological Process (1): regulation of transcription by RNA polymerase II (GO:0006357)
GO Molecular Function (4): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), DNA binding (GO:0003677), protein binding (GO:0005515)
GO Cellular Component (2): chromatin (GO:0000785), nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| chromosome | 1 |
| cellular anatomical structure | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
398 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| HDX | SMIM1 | B2RUZ4 | 572 |
| HDX | HOMEZ | Q8IX15 | 394 |
| HDX | TRO | Q12816 | 364 |
| HDX | KRT86 | P78387 | 336 |
| HDX | PSME3 | P61289 | 325 |
| HDX | DYM | Q7RTS9 | 313 |
| HDX | GNAS | Q5JWF2 | 305 |
| HDX | POLE | Q07864 | 296 |
| HDX | RFX2 | P48378 | 290 |
| HDX | CFAP52 | Q8N1V2 | 284 |
| HDX | PSME2 | Q9UL46 | 276 |
| HDX | GNS | P15586 | 271 |
| HDX | PAMR1 | Q6UXH9 | 270 |
| HDX | TGIF2LX | Q8IUE1 | 270 |
| HDX | PSME1 | Q06323 | 269 |
| HDX | TGIF2LY | Q8IUE0 | 269 |
IntAct
53 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| HDX | SUFU | psi-mi:“MI:0915”(physical association) | 0.670 |
| SUFU | HDX | psi-mi:“MI:0915”(physical association) | 0.670 |
| BOLA2-SMG1P6 | HDX | psi-mi:“MI:0915”(physical association) | 0.560 |
| POLR1C | HDX | psi-mi:“MI:0915”(physical association) | 0.560 |
| HDX | MID2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| HDX | BOLA1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| HDX | RTN4IP1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| HDX | TSGA10 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CCDC57 | HDX | psi-mi:“MI:0915”(physical association) | 0.560 |
| HDX | GCC1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| HDX | LNX1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| HDX | CTNNA3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LMO1 | HDX | psi-mi:“MI:0915”(physical association) | 0.560 |
| FHL5 | HDX | psi-mi:“MI:0915”(physical association) | 0.560 |
| HDX | TTC5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZBTB16 | HDX | psi-mi:“MI:0915”(physical association) | 0.370 |
| Arhgap33 | MAP3K7 | psi-mi:“MI:0914”(association) | 0.350 |
| Arhgap18 | KRT86 | psi-mi:“MI:0914”(association) | 0.350 |
| CTBP1 | GSN | psi-mi:“MI:0914”(association) | 0.350 |
| MAPT | SHTN1 | psi-mi:“MI:0914”(association) | 0.350 |
| SCRIB | CHD2 | psi-mi:“MI:0914”(association) | 0.350 |
| POLR1E | HDX | psi-mi:“MI:0915”(physical association) | 0.000 |
| BOLA2-SMG1P6 | HDX | psi-mi:“MI:0915”(physical association) | 0.000 |
| POLR1C | HDX | psi-mi:“MI:0915”(physical association) | 0.000 |
| MID2 | HDX | psi-mi:“MI:0915”(physical association) | 0.000 |
| BOLA1 | HDX | psi-mi:“MI:0915”(physical association) | 0.000 |
| TTC5 | HDX | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (38): HDX (Affinity Capture-MS), HDX (Affinity Capture-MS), HDX (Affinity Capture-MS), HDX (Affinity Capture-MS), HDX (Two-hybrid), HDX (Two-hybrid), HDX (Two-hybrid), HDX (Two-hybrid), HDX (Two-hybrid), HDX (Two-hybrid), HDX (Two-hybrid), LMO1 (Two-hybrid), BOLA2B (Two-hybrid), POLR1C (Two-hybrid), CCDC57 (Two-hybrid)
ESM2 similar proteins: A0AVK6, A4L9P5, B2GUN4, D2HNW6, D3ZGB1, E1BKK0, E1BP74, E1BZ85, F1LMN3, O14607, O15164, O15550, O70546, O88850, O88904, O94916, Q14B70, Q58CW6, Q58FA4, Q5RJA1, Q5ZKW8, Q64127, Q6B4Z3, Q7Z353, Q7Z3K3, Q84VX4, Q86Z02, Q8BJ34, Q8BZH4, Q8C7R7, Q8HWS3, Q8IXK0, Q8K0L9, Q8N187, Q93073, Q99743, Q99MQ1, Q99PP7, Q9BYH8, Q9ERH7
Diamond homologs: Q14B70, Q5ZKW8, Q7Z353
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
142 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 58 |
| Likely benign | 3 |
| Benign | 6 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2332 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| X:84326172:ACCT:A | donor_loss | 1.0000 |
| X:84326176:ACC:A | donor_loss | 1.0000 |
| X:84326177:C:CT | donor_loss | 1.0000 |
| X:84326177:CCTG:C | donor_gain | 1.0000 |
| X:84326297:CATT:C | acceptor_gain | 1.0000 |
| X:84326299:TT:T | acceptor_gain | 1.0000 |
| X:84326300:TC:T | acceptor_loss | 1.0000 |
| X:84326301:C:CC | acceptor_gain | 1.0000 |
| X:84326302:T:A | acceptor_loss | 1.0000 |
| X:84333755:CTA:C | donor_loss | 1.0000 |
| X:84333757:A:C | donor_loss | 1.0000 |
| X:84333839:TTTT:T | acceptor_gain | 1.0000 |
| X:84333840:TTT:T | acceptor_gain | 1.0000 |
| X:84333841:TT:T | acceptor_gain | 1.0000 |
| X:84333841:TTC:T | acceptor_loss | 1.0000 |
| X:84333842:TCT:T | acceptor_loss | 1.0000 |
| X:84333843:C:CA | acceptor_loss | 1.0000 |
| X:84333843:C:CC | acceptor_gain | 1.0000 |
| X:84333849:C:CT | acceptor_gain | 1.0000 |
| X:84336795:ACAT:A | donor_loss | 1.0000 |
| X:84336797:ATACC:A | donor_loss | 1.0000 |
| X:84336798:TA:T | donor_loss | 1.0000 |
| X:84336799:A:AC | donor_gain | 1.0000 |
| X:84336799:A:AG | donor_loss | 1.0000 |
| X:84336800:C:CC | donor_gain | 1.0000 |
| X:84336800:CCA:C | donor_gain | 1.0000 |
| X:84336876:CTCTT:C | acceptor_gain | 1.0000 |
| X:84336878:CTT:C | acceptor_gain | 1.0000 |
| X:84336879:TT:T | acceptor_gain | 1.0000 |
| X:84336879:TTCTA:T | acceptor_loss | 1.0000 |
AlphaMissense
4544 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| X:84344454:A:G | W486R | 1.000 |
| X:84344454:A:T | W486R | 1.000 |
| X:84361470:A:T | V483D | 1.000 |
| X:84469570:C:A | W51C | 1.000 |
| X:84469570:C:G | W51C | 1.000 |
| X:84469572:A:G | W51R | 1.000 |
| X:84469572:A:T | W51R | 1.000 |
| X:84475255:A:T | V48D | 1.000 |
| X:84475263:G:C | F45L | 1.000 |
| X:84475263:G:T | F45L | 1.000 |
| X:84475265:A:G | F45L | 1.000 |
| X:84475270:A:G | L43P | 1.000 |
| X:84475287:A:C | C37W | 1.000 |
| X:84475289:A:G | C37R | 1.000 |
| X:84475305:A:C | F31L | 1.000 |
| X:84475305:A:T | F31L | 1.000 |
| X:84475306:A:C | F31C | 1.000 |
| X:84475307:A:G | F31L | 1.000 |
| X:84475330:A:G | M23T | 1.000 |
| X:84475354:A:G | L15S | 1.000 |
| X:84475378:A:G | F7S | 1.000 |
| X:84344434:C:A | R492S | 0.999 |
| X:84344434:C:G | R492S | 0.999 |
| X:84344435:C:G | R492T | 0.999 |
| X:84344437:T:A | R491S | 0.999 |
| X:84344437:T:G | R491S | 0.999 |
| X:84344438:C:G | R491T | 0.999 |
| X:84344441:C:G | R490P | 0.999 |
| X:84344452:C:A | W486C | 0.999 |
| X:84344452:C:G | W486C | 0.999 |
dbSNP variants (sampled 300 via entrez): RS1000004518 (X:84466642 A>C), RS1000012299 (X:84400672 T>A,C), RS1000046092 (X:84473446 G>A), RS1000047111 (X:84405844 A>G), RS1000067807 (X:84459230 C>T), RS1000097273 (X:84353390 G>A), RS1000150821 (X:84490179 T>C), RS1000183713 (X:84339520 G>A), RS1000197765 (X:84343611 G>A), RS1000215885 (X:84483114 C>A,G), RS1000236145 (X:84339950 G>A), RS1000247262 (X:84320238 A>G), RS1000251168 (X:84373242 T>C), RS1000262378 (X:84427996 T>G), RS1000266843 (X:84483611 G>A)
Disease associations
OMIM: gene MIM:300994 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST008295_8 | Number of decayed, missing and filled tooth surfaces or use of dentures | 2.000000e-08 |
| GCST008306_22 | Dentures | 2.000000e-07 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0010078 | dentures |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
20 total (human), top 20 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects expression, decreases expression, decreases methylation, increases expression | 6 |
| Benzo(a)pyrene | affects methylation, increases expression | 2 |
| aristolochic acid I | decreases expression | 1 |
| GSK-J4 | decreases expression | 1 |
| TAK-243 | increases sumoylation | 1 |
| sodium arsenite | decreases expression | 1 |
| ferrous chloride | decreases expression | 1 |
| entinostat | decreases expression | 1 |
| abrine | increases expression | 1 |
| jinfukang | affects cotreatment, decreases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Acetaminophen | increases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Amiodarone | increases expression | 1 |
| Cisplatin | affects cotreatment, decreases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Thimerosal | increases expression | 1 |
| Cyclosporine | increases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Particulate Matter | decreases expression, increases abundance | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.